ROR2

ROR2 분자 정보

영어 이름Tyrosine-protein kinase transmembrane receptor ROR2시판 약물 수0
임상 약물 수1표적 별명EC:2.7.10.1,ROR2,NTRKR2,Receptor Tyrosine Kinase Like Orphan Receptor 2,Tyrosine-Protein Kinase Transmembrane Receptor ROR2,Neurotrophic Tyrosine Kinase, Receptor-Related 2,Neurotrophic Tyrosine Kinase Receptor-Related 2,Receptor Tyrosine Kinase-Like Orphan Receptor 2,EC 2.7.10.1,BDB1,BDB
최고 연구 개발 단계Phase 2 Clinical
영어 이름Tyrosine-protein kinase transmembrane receptor ROR2
표적 별명EC:2.7.10.1,ROR2,NTRKR2,Receptor Tyrosine Kinase Like Orphan Receptor 2,Tyrosine-Protein Kinase Transmembrane Receptor ROR2,Neurotrophic Tyrosine Kinase, Receptor-Related 2,Neurotrophic Tyrosine Kinase Receptor-Related 2,Receptor Tyrosine Kinase-Like Orphan Receptor 2,EC 2.7.10.1,BDB1,BDB
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 2 Clinical

ROR2 제품 목록

  • 속성

    Protein (6)

  • 제품 라이브러리

    온라인 (6)

  • Human (3)Mouse (2)Cynomolgus (1)

  • 태그

    Fc Tag (2)His Tag (3)His Tag & Avi Tag (1)

  • 마커

    Unconjugated (5)Biotin-labeled (1)

ROR2분자 배경

Tyrosine-protein kinase transmembrane receptor ROR2 is also known as Neurotrophic tyrosine kinase, receptor-related 2 (NTRKR2), which belongs to the protein kinase superfamily and Tyr protein kinase family and ROR subfamily. ROR2 is a homodimer protein, which can binds YWHAB or interact with WTIP. ROR2 may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development.

ROR2분자 별명

ROR2,NTRKR2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Ozuriftamab VedotinHTBA-3021; CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021Phase 2 ClinicalBioatlaCarcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호